Better way to develop vaccine against flu virus identifiedMay 13th, 2009 - 12:40 pm ICT by ANI
Washington, May 13 (ANI): By cashing-in on the interaction between a virus and antibodies that fight infection, Princeton University scientists may have discovered a better way to make a vaccine against the flu virus.
The researchers have said that by manipulating the multi-stage interactive process- called antibody interference-to advantage, it could be possible to design more powerful vaccines than exist today.
“We have proposed that antibody interference plays a major role in determining the effectiveness of the antibody response to a viral infection. And we believe that in order to get a more powerful vaccine, people are going to want one that minimizes this interference,” said Ned Wingreen, a professor of molecular biology.
When Ndifon and colleagues analysed data about viral structure, antibody types and the reactions between them produced by virology laboratories across the country, they noticed a confusing pattern.
They found that antibodies were often better at protecting against a slightly different virus, a close cousin, than against the virus that spurred their creation-a process known as cross-reactivity.
On a closer look, they found that a phenomenon known as antibody interference was at play-it arises when a virus prompts the creation of multiple types of antibodies.
As a result, during a viral attack, antibodies vie with each other to defend the body, and sometimes crowd each other out while they attempt to attach themselves to the surface of the virus.
But, strangely, antibodies that are actually less effective at protecting the body against a specific virus are also equally adept at attaching themselves to the virus, blocking the more effective antibodies from doing their job.
Thus, the scientists have suggested that if a way can be found to weaken the binding of the less effective antibodies, this might constitute a new approach to vaccine design.
The researchers claimed that the pattern of enhanced cross-reactivities could easily be attributed to viruses that differ only at the sites on their surfaces where the less effective antibodies bind.
Such variants would make ideal vaccine strains, guiding the immune system to produce two distinct types of antibodies: effective ones that are well matched to and good at binding to the infecting virus, and ineffective ones that are poorly matched to and bad at binding to the infecting virus, and consequently stay out of the way.
The findings have been described in the online edition of the Proceedings of the National Academy of Sciences. (ANI)
- Researchers find better way to make flu virus vaccine - May 13, 2009
- New findings bring scientists closer to an effective HIV vaccine - Jan 15, 2011
- The reason behind mildness of 2009 H1N1 pandemic - Jun 19, 2010
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- Effective antibodies against flu strains identified - Aug 10, 2012
- Vaccine-delivering nanoparticles may help fight HIV, malaria - Feb 23, 2011
- Novel vaccine that produces strong immunity against cocaine high created - Jan 05, 2011
- Promising target for AIDS vaccine identified - Apr 01, 2011
- 'Pep talk' can revive exhausted immune cells: Study - Dec 14, 2011
- Soon, nasal spray vaccines to curb flu - Apr 12, 2011
- Built-in dengue virus killer found in humans - Jun 24, 2012
- Tweaking antibody could lead to vaccine against HIV - May 08, 2011
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Scientists 1 step closer to developing treatment for chikungunya - Feb 16, 2011
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
Tags: antibody response, closer look, cousin, cross reactivity, fight infection, flu, flu virus, interference, molecular biology, new approach, phenomenon, princeton university, types of antibodies, university scientists, vaccine design, vaccines, viral attack, viral infection, viral structure, virology laboratories